SCHEMBL3392407

SCHEMBL3392407

CCNC(=N)N(N=O)[N+](=O)[O-]

nearest known ligand 0.43

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.43
TP53 P04637 1/20 0.43
LMNA P02545 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7006371 0.85 ALDH1A1 (0.41) ALDH1A1TP53
SCHEMBL49441 0.78 ALDH1A1 (0.47) ALDH1A1TP53
SCHEMBL5847098 0.74 ALDH1A1 (0.62) ALDH1A1TP53
SCHEMBL623332 0.66
SCHEMBL1168085 0.64 ALDH1A1 (0.59) ALDH1A1TP53LMNA
SCHEMBL3812521 0.64 ALDH1A1 (0.38) ALDH1A1TP53
SCHEMBL6744089 0.63 NOS1 (0.31)
SCHEMBL1819959 0.63
SCHEMBL6878279 0.63 ALDH1A1 (0.38) ALDH1A1LMNA
SCHEMBL5551260 0.62 ALDH1A1 (0.56) ALDH1A1TP53LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 69 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240271119-A1 METHODS OF PERIPLASMIC PHAGE-ASSISTED CONTINUOUS EVOLUTION THE BROAD INSTITUTE, INC. (US) 2024-08-15 US claimed
EP-3199630-B1 CONTINUOUS DIRECTED EVOLUTION OF PROTEINS AND NUCLEIC ACIDS HARVARD COLLEGE (US) 2019-05-08 EP claimed
US-9771574-B2 Apparatus for continuous directed evolution of proteins and nucleic acids PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 2017-09-26 US claimed
EP-3199630-A1 CONTINUOUS DIRECTED EVOLUTION OF PROTEINS AND NUCLEIC ACIDS President and Fellows of Harvard College (US) 2017-08-02 EP claimed
WO-2016077052-A9 EVOLUTION OF PROTEASES PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 2016-07-21 WO claimed
WO-2016077052-A2 EVOLUTION OF PROTEASES PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 2016-05-19 WO claimed
US-20150275202-A1 CONTINUOUS DIRECTED EVOLUTION OF PROTEINS AND NUCLEIC ACIDS PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 2015-10-01 US claimed
US-9023594-B2 Continuous directed evolution of proteins and nucleic acids PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 2015-05-05 US claimed
WO-2010028347-A2 CONTINUOUS DIRECTED EVOLUTION OF PROTEINS AND NUCLEIC ACIDS PRESIDENT & FELLOWS OF HARVARD COLLEGE (US) 2010-03-11 WO claimed
US-12398390-B2 Negative selection and stringency modulation in continuous evolution systems PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 2025-08-26 US disclosed
US-12366009-B2 Continuous directed evolution PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 2025-07-22 US disclosed
US-20250195627-A1 GTP CYCLOHYDROLASE-CLEAVING PROTEASES THE BROAD INSTITUTE, INC. (US) 2025-06-19 US disclosed
US-20250109177-A1 EVOLVED PROTEIN DEGRONS THE BROAD INSTITUTE, INC. (US) 2025-04-03 US disclosed
US-20240287491-A1 PROCASPASE-CLEAVING PROTEASES AND USES THEREOF THE BROAD INSTITUTE, INC. (US) 2024-08-29 US disclosed
US-9023594-B2 Continuous directed evolution of proteins and nucleic acids PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 2015-05-05 US disclosed
US-20130345064-A1 CONTINUOUS DIRECTED EVOLUTION PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 2013-12-26 US disclosed
WO-2010028347-A2 CONTINUOUS DIRECTED EVOLUTION OF PROTEINS AND NUCLEIC ACIDS PRESIDENT & FELLOWS OF HARVARD COLLEGE (US) 2010-03-11 WO disclosed
WO-2004084705-A2 QUANTITATIVE DETECTION OF H. PYLORI IN BIOLOGICAL SAMPLES UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES (US) 2004-10-07 WO disclosed
US-4035568-A Derivatives of polyene macrolide antibiotics RUTGERS RESEARCH AND EDUCATIONAL FOUNDATION (US) 1977-07-12 US disclosed
US-3945993-A Derivatives of polyene macrolide antibiotics RUTGERS RESEARCH AND EDUCATIONAL FOUNDATION (US) 1976-03-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250109177-A1 EVOLVED PROTEIN DEGRONS SRP72, TIA1, SMURF1 ALDH1A1 4776/4885TP53 5/4885LMNA 3024/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.